Squarepoint Ops LLC Corvus Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$93.7 Billion
Q2 2025

A detailed history of Squarepoint Ops LLC transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 138,462 shares of CRVS stock, worth $623,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares

138,462

Previous 101,032 37.05%

Holding current value

$623,079

Previous $321,000 72.27%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.82 - $4.5 $105,552 - $168,435	37,430 Added 37.05%	138,462 $553,000
Q1 2025 May 15, 2025	BUY	$3.18 - $6.03 $9,183 - $17,414	2,888 Added 2.94%	101,032 $321,000
Q4 2024 Feb 14, 2025	BUY	$4.55 - $9.56 $391,591 - $822,771	86,064 Added 712.45%	98,144 $510,000
Q3 2024 Nov 14, 2024	BUY	$1.78 - $5.92 $21,502 - $71,513	12,080 New	12,080 $63,000
Q2 2023 Aug 14, 2023	BUY	$1.0 - $3.86 $17,082 - $65,936	17,082 New	17,082 $39,000
Q1 2022 May 16, 2022	SELL	$1.46 - $2.48 $19,152 - $32,532	-13,118 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.34 - $5.31 $15,996 - $36,299	-6,836 Reduced 34.26%	13,118 $32,000
Q3 2021 Nov 15, 2021	BUY	$1.89 - $8.53 $37,713 - $170,207	19,954 New	19,954 $97,000
Q3 2020 Nov 16, 2020	SELL	$2.6 - $5.37 $68,686 - $141,864	-26,418 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.01 - $4.05 $3,983 - $8,027	1,982 Added 8.11%	26,418 $72,000
Q1 2020 May 15, 2020	BUY	$1.74 - $5.98 $42,518 - $146,127	24,436 New	24,436 $52,000
Q2 2019 Aug 14, 2019	SELL	$3.3 - $4.58 $151,090 - $209,695	-45,785 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$3.75 - $4.97 $103,758 - $137,514	-27,669 Reduced 37.67%	45,785 $184,000
Q4 2018 Feb 14, 2019	BUY	$3.29 - $8.94 $74,452 - $202,312	22,630 Added 44.53%	73,454 $270,000
Q3 2018 Nov 14, 2018	BUY	$8.58 - $11.4 $306,915 - $407,789	35,771 Added 237.63%	50,824 $436,000
Q2 2018 Aug 14, 2018	BUY	$9.42 - $13.73 $15,778 - $22,997	1,675 Added 12.52%	15,053 $165,000
Q1 2018 May 15, 2018	BUY	$7.48 - $11.53 $100,067 - $154,248	13,378 New	13,378 $154,000

Others Institutions Holding CRVS

# of Institutions

102

Shares Held

38.9M

Call Options Held

145K

Put Options Held

241K

View Full List

About Corvus Pharmaceuticals, Inc.

Ticker CRVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,553,500
Market Cap $209M
Description
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...

More about CRVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Corvus Pharmaceuticals, Inc. Transaction History